Skip to main content
  • 53.75%
    Share capital 30/09/2018
  • 2,725 EUR M
    Value of the stake 30/09/2018
  • 67.54%
    Voting rights 30/09/2018
  • 3
    Number of representatives in statutory bodies 30/09/2018
Investment Year 1987 Investment history

Imerys extracts, transforms, develops and combines a unique range of minerals to provide functionalities that are key to its customers' products and production processes. These specialities have a very wide range of uses and are becoming increasingly common on growing markets.


Performance in 2017

In 2017, the group’s results improved substantially and its cash flow generation was robust. Imerys largely exceeded its growth target for net income from current operations.

2017 was a major year in the rollout of Imerys’ strategy. The group broadened its business portfolio with the acquisition of Kerneos, the world leader in calcium aluminate specialties on the fast-growing building chemicals market. It enhanced its existing offering through several bolt-on acquisitions and developed its international footprint, particularly in China.

Kerneos is consolidated since 18 July 2017 and is already contributing to Imerys’ development. The group confirms its value creation targets, including annual synergies estimated at EUR 23 million within 3 years.

Imerys also completed several bolt-on acquisitions in 2017, which contributed for EUR 133 million to the revenue for the financial year and enabled the group to broaden its specialty offering and develop its geographic presence in emerging countries such as Brazil, India and particularly China, where the group now generates more than 7% of its revenue.

At the General Meeting of May 4, 2018, the Board of Directors will propose a dividend of EUR 2.075 per share, corresponding to an 11% increase compared with 2017 and to 41% of the group’s share of net income from current operations.

Investment case

  • Resilience of the business model
  • Geographic and customer’s final markets diversity
  • Leader in its sector: #1 or #2 in almost all of its markets
  • High added value functional products providing key properties to its customers’ products
  • Low exposure to fluctuations in commodities prices
  • Low risk of substitution due to the low share in the customers' total costs
  • Solid cash-flow generation making it possible to support external growth


Audit Committee (1/4*) Boards of Directors (3/14*) Strategic Committee (3/8*) Appointments Committee (2/5*) Remuneration Committee (2/6*)
Member Member Member Member
Member Member Member Member
Member Member Member
* Number of GBL's representatives in statutory bodies in relation to the total number of members. Governance information is dated 31/12/2017, except where superseded by more recent public disclosures.